Is creating new medtech easy? No, but when there's a market need and you strategically create products that manage risks (we call it BUTR; Business, User, Technology, and Regulatory), then that's when innovation and business success can really come together to have an impact in the market. Congratulations to Pulmvita Inc. for achieving another key product commercialization milestone and thank you for trusting us with your project Cole Christianson and Andrew Martin! We applaud your dedication to helping those with pulmonary illness lead more active and fulfilling lives! Andy Josephs, P.Eng, Mason Ledinski, Davide Veronesi, Courtney MacDonald, P.Eng., Avery Reinhardt #innovation #healthtech #tech #medtech https://lnkd.in/gN3jVQ4P
Exciting news! We are officially starting patient trials for our new nasal cannula. The PillowsPlus Cannula is designed to improve oxygenation and comfort for long-term oxygen therapy patients. If you are interested in being a participant, know someone who could benefit from the PillowsPlus, or would like more information please reach out to us through our page or by email: info@pulmvita.com Efrem Violato, Emilio Violato, Andrew Martin, George Vis, Daniel Vis, Cole Christianson